Mutke, Matthias A. https://orcid.org/0000-0002-2101-823X
Potreck, Arne https://orcid.org/0000-0001-9206-2636
Schmitt, Niclas https://orcid.org/0000-0003-2509-5459
Seker, Fatih https://orcid.org/0000-0001-6072-0438
Ringleb, Peter A. https://orcid.org/0000-0002-5473-8671
Nagel, Simon https://orcid.org/0000-0003-2471-6647
Möhlenbruch, Markus A. https://orcid.org/0000-0002-5075-704X
Bendszus, Martin https://orcid.org/0000-0002-9094-6769
Weyland, Charlotte S. https://orcid.org/0000-0002-1374-7854
Jesser, Jessica https://orcid.org/0000-0002-1236-8828
Funding for this research was provided by:
Medizinische Fakultät Heidelberg der Universität Heidelberg
Article History
Received: 23 June 2022
Accepted: 25 October 2022
First Online: 2 December 2022
Declarations
:
: M.A. Mutke, A. Potreck, N. Schmitt, P.A. Ringleb, F. Seker, C.S. Weyland and J. Jesser declare that they have no competing interests. S. Nagel has no related disclosures, unrelated disclosures: consultancy: Brainomix, Boehringer Ingelheim; payment for lectures including service on speakers bureaus: Pfizer, Medtronic, Bayer AG. M.A. Möhlenbruch has no related disclosures, unrelated disclosures: board membership: Codman; consultancy: Medtronic, MicroVention, Stryker; Grants/Grants Pending: Balt*, MicroVention*; payment for lectures including service on speakers bureaus: Medtronic, MicroVention, Stryker; *money paid to the institution. M. Bendszus has not related disclosures, unrelated disclosures: grants and personal fees from Bayer, Codman, Guerbet, Medtronic and Novartis; grants from the German Research Council (DFG), European Union, Hopp Foundation, Siemens, and Stryker; personal fees from BBraun, Böhringer Ingelheim, Roche, Teva, and Vascular Dynamics.
: This study was approved by the local ethics committee (Ethikkommission der Universität Heidelberg). Informed consent was waived due to the retrospective nature of this study. The study was conducted following the STROBE criteria.